Read Now: News & Research From CROI 2015

International News

Large-Scale Trial of Vaginal Ring That Releases Anti-HIV Drug Announced at Health Summit in London

From Henry J. Kaiser Family Foundation

June 15, 2012

"This week, at the Pacific Health Summit in London, the final large-scale trial was officially launched of a vaginal ring which women can wear and forget about -- at least for a month at a time -- while it releases an HIV virus-killing drug called dapivirine," the Guardian reports. "If successful, it could also be combined with hormonal contraception," the newspaper notes. The phase III clinical trial, "launched by the International Partnership for Microbicides, is already recruiting women in South Africa, Rwanda and Malawi" and "will involve 1,650 women -- enough to prove definitively whether it works," according to the newspaper (Boseley, 6/13).

Back to other news for June 2012

This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

Less Expensive ARV Combination Just as Effective for Women in Developing Countries as Costlier ARVs, Study Shows

HAART May Not Be Enough to Normalize Immune Aging in Women, Study Finds

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.

What Did You Expect While You Were Expecting?

HIV/AIDS Resource Center for Women

No comments have been made.

Add Your Comment:

(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Women and PrEP: The Bridging Role of Local Health Departments

Inflammation Persists Despite Very Early HIV Treatment

Coverage of CROI 2015: The 22nd Conference on Retroviruses and Opportunistic Infections

Biggest HIV Developments From CROI Over the Past 3 Years

Study Explores Risk for Shingles in the Current Era

More >>

TheBodyPRO.com is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.